Investment Announcements2019-02-11T20:15:27-06:00

Investment Announcements: News & Recent Transactions

Shore Capital Partners announced sale of Florida Autism Center

March 4, 2020 – Shore Capital Partners (“Shore”), a Chicago-based private equity firm focused on microcap investments within the Healthcare and Food and Beverage industries, is pleased to announce the sale of its autism services portfolio company, Florida Autism Center / Fusion Autism Center (“FAC”), to BlueSprig Pediatrics (“BlueSprig”), a leading Houston, Texas based provider of autism services. Shore Capital partnered with FAC founder Chryssy Moor’s four locations in 2015 with a goal of building the leading autism services platform in the southeast. Led by Chief Executive Officer Kristy Rohwedder, the team at FAC has evolved from its entrepreneurial beginnings [...]

Shore Capital Partners Announces Partnership with Main Street Gourmet

September 19, 2019 ‐ Founded in 1987 by Steve Marks and Harvey Nelson, Main Street Gourmet is a custom wholesale bakery providing frozen baked goods, including muffins, cookies, granola, brownies and bars, and other sweet goods to retail in-store bakery (“ISB”) and specialty foodservice customers across the United States. MSG operates out of an SQF certified 68,000 sq. foot manufacturing facility with approximately 160 employees in Akron, OH, and has been an important part of the community for more than 30 years. Shore Capital is partnering with Mr. Marks and Mr. Nelson, the full MSG management team, and the previous [...]

Shore Capital Announces Formation of Southern Ear, Nose, Throat, and Allergy Partners

May 17, 2019 ‐ Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has formed Southern Ear, Nose, Throat and Allergy Partners (“SENTA”) and completed a strategic partnership with Northwest ENT and Allergy Center (“Northwest ENT” or the “Company”). Northwest ENT is a leading ear, nose and throat (“ENT”) and allergy services provider with seven locations including two affiliated ambulatory surgery centers in the Greater Atlanta, Georgia metro area. The Company offers comprehensive medical and surgical ENT and allergy services, including treatment for thyroid disorders, sinus conditions, ear pain, allergies, and throat disorders. Northwest ENT will continue to [...]

Shore Capital Partners Closes On Veterinary Platform Investment

CHICAGO – November 1, 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce the recapitalization of Advanced Animal Hospital Group and Progressive Pet Animal Hospitals and merger of the respective businesses to form Midwest Veterinary Partners (“MVP” or the “Company”). The Company has 22 general practice veterinary clinics in Michigan, Wisconsin, and Illinois, and provides services to companion animals including vaccinations, surgery, wellness exams, oncology, ophthalmology, allergy treatment and dermatology. Financial terms of the transaction were not disclosed.Shore has partnered with Dr. Vic Dhillon, owner of Advanced Animal Hospital Group, and Dr. Jeff Rothstein, owner of [...]

Shore Capital Partners Invests In a Comprehensive Addiction Treatment Platform

CHICAGO – November 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce the recapitalization of BrightView, LLC (“BrightView” or the “Company”). Headquartered in Cincinnati, the Company currently has 4 locations in Ohio and provides psychological, social and medical services, including medication assisted treatment, to individuals suffering from addiction. Financial terms of the transaction were not disclosed. Shore has partnered with BrightView to increase access to effective comprehensive addiction treatment throughout Ohio and the surrounding states. Chad Smith, Chief Executive Officer (CEO), co-founded the Company in 2014 and has successfully led and grown the business, opening centers [...]

Navia Benefit Solutions Announces Partnership with Shore Capital Partners

Renton, WA – November 2017 – Navia Benefit Solutions, Inc. is pleased to announce that it has formed a growth partnership with Shore Capital Partners, a Chicago-based private equity firm focused on the healthcare industry.  Founded in 1989, Navia is a leading third-party administrator (“TPA”) of consumer directed health benefit solutions serving clients nationwide. Shore partnered with Hilarie Aitken and Matt Aitken who have led Navia through a period of tremendous growth since taking an active leadership role in 2003 following the passing of their father, Stan Aitken.  Under the name Flex-Plan Services, Inc., Brothers Stan and Jim Aitken founded Navia in [...]

Shore Capital Partners and EyeSouth Partners Expand Through Affiliation with Georgia Retina

ATLANTA, GA, August 2, 2017 – Shore Capital Partners ("Shore Capital"), a leading lower middle market healthcare private equity firm, is pleased to announce its portfolio company EyeSouth Partners (“EyeSouth” or the “Company”) has completed a strategic partnership with Georgia Retina, one of the largest retina medical practices in the Southeast. “Our primary aim at Georgia Retina has always been to deliver exceptional medical and surgical retinal care combined with an outstanding patient experience,” said Dr. Michael Jacobson, who along with Dr. Scott Lampert founded Georgia Retina in 1994. “To further and build upon this mission in the rapidly changing healthcare [...]

Shore Capital Closes Recap of Behavioral Innovations

June 5, 2017 ‐ Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has completed a recapitalization of Behavioral Innovations (“BI” or the “Company”) and formed SCP Behavioral Innovations HoldCo, LLC. Behavioral Innovations provides center-based and in-home applied behavior analysis therapy (“ABA”), speech therapy (“SLP”) and occupational therapy (“OT”) services to children ages birth through 18 with autism spectrum disorder and other related developmental disabilities. In addition, BI offers adult services in community-based treatment settings. Behavioral Innovations has 13 centers in central and northern Texas and in-home services in the Oklahoma City, OK area. Shore has partnered with [...]

Shore Capital Partners Announces Acquisition of Spine Assets from Cook Medical

May 10, 2017 ‐ Shore Capital Partners, LLC (“Shore Capital” or “Shore”) is pleased to announce that IZI Medical Products, LLC (“IZI Medical” or “IZI”), its interventional products platform, has acquired the vertebroplasty family of products from Cook Medical (“Cook”).  The acquired portfolio of products are commercially marketed under the highly regarded Duro-Ject® Osteo-Site®, Osteo-Force® and Vertefix® brands, consisting of needles, injectors and cements.  These products are used in the growing market for treating vertebral compression fractures through a minimally invasive procedure. “Cook has done an excellent job establishing these products as reliable, high-quality solutions for treating vertebral compression fractures and [...]

Shore Capital Partners announced formation of EyeSouth Partners, completes affiliation with Georgia Eye Partners

March 14, 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) is pleased to announce that it has formed EyeSouth Partners, LLC and completed a strategic partnership with Georgia Eye Partners (“Georgia Eye” or the “Company”). Founded in 1999 by Dr. Eugene Gabianelli, Georgia Eye is a leading eye care practice with four locations in the Atlanta, Georgia area. The Company offers medical and surgical specialty eye care services, including treatment for cataracts, corneal disease, refractive surgery, glaucoma, and oculoplastics through OPAL Aesthetics. Shore Capital is proud to partner with Georgia Eye’s three partner physicians, Dr. Eugene Gabianelli (“Gino”), Dr. Andrew Feinberg [...]

Shore Capital Partners announced an investment in Argentum Medical

January 20, 2017 – Shore Capital Partners (“Shore Capital” or “Shore”) today announced that it has completed a growth investment in Argentum Medical, LLC and certain assets of Cura Surgical, Inc. (“Argentum” or the “Company”). Founded in 2001 and located in Geneva, IL, Argentum manufactures and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products. The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing [...]

Shore Capital Partners announced sale of ClearPath Diagnostics

October 3, 2016 – Shore Capital Partners ("Shore Capital"), a healthcare-focused private equity firm, today announced the sale of ClearPath Diagnostics ("ClearPath"), a leading provider of laboratory diagnostic services in the Northeastern United States, to Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world's leading healthcare diagnostics company. Shore Capital partnered with ClearPath's founding pathologists, Dr. Michael Jozefczyk and Dr. Michael Mazur, to drive the company's expansion beyond the local Syracuse, New York market. Together, Shore Capital and ClearPath executed a growth strategy that extended the company's geographic reach to four states and expanded the service menu to include new cutting-edge [...]

Shore Capital Partners announced sale of Fast Pace Urgent Care

August 23, 2016 – Shore Capital Partners (“Shore Capital”) a healthcare-focused private equity firm, is pleased to announce the sale of Fast Pace Urgent Care (“Fast Pace”), a leading provider of urgent care services throughout rural Tennessee and Kentucky, to Revelstoke Capital Partners. In December 2012, Shore Capital partnered with Fast Pace founders, Stan Bevis and Reams Powers, to help grow their initial seven urgent care locations. Shore Capital and Fast Pace together executed an accelerated growth plan and expanded the business from seven to 36 clinics in approximately three and a half years. The growth came primarily through de novo expansion as [...]

Shore Capital Partners announces sale of Sirona Infusion, LLC, Access I.V., LLC, HomeCare IV, and InfuSource

November 25, 2013 – Shore Capital Partners (“Shore”), a healthcare-focused private equity firm, is pleased to announce the sale of its home infusion therapy portfolio company, SCP Specialty Infusion, to AxelaCare Health Solutions, a leading provider of specialty home infusion services specializing in IVIg (immune globulin). In November 2009, Shore partnered with Chris York, CEO, and Mitch Friedman, CFO, long time home infusion industry veterans, to complete a roll-up strategy in the space. In July 2010, the management team and Shore made their platform investment in Arizona-based Sirona Infusion, LLC. Over the next three and a half years, Shore and management completed [...]

Shore Announces Sale of Excel Rehabilitation Services, Michigan Rehabilitation Specialists, Quantum Physical Therapy, and MRS Davison

August 5, 2013 – Shore Capital Partners (“Shore”), a healthcare-focused private equity firm, is pleased to announce the sale of its physical therapy portfolio company SCP Physical Therapy to ATI Physical Therapy, a nationally recognized comprehensive rehabilitation provider, specializing in research-based physical therapy, sports medicine, work conditioning/hardening, functional capacity assessments, aquatic health, hand therapy and women’s health. In May 2012, Shore acquired and merged two physical therapy companies, Michigan Rehabilitation Specialists (“MRS”) and Excel Rehabilitation Services (“Excel”) into SCP Physical Therapy. Together, Shore and the company’s management expanded the company’s presence in Michigan from 17 clinics to 33 clinics through aggressive new [...]